Market revenue in 2022 | USD 1,227.1 million |
Market revenue in 2030 | USD 1,616.0 million |
Growth rate | 3.5% (CAGR from 2022 to 2030) |
Largest segment | Viscosupplements |
Fastest growing segment | Synthetic |
Historical data covered | 2016 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Allografts, Synthetic, Cell-based, Viscosupplements |
Key market players worldwide | Anika Therapeutics Inc, Vericel Corp, Baxter International Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Smith & Nephew PLC, BioTissue, MiMedx Group Inc, Arthrex, AlloSource, VSY Biotechnology, Aptissen |
Key Regions: Brazil , UK , U.S. , Japan , South Africa
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic regenerative surgical products market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 41.44% in 2022. Horizon Databook has segmented the Europe orthopedic regenerative surgical products market based on allografts, synthetic, cell-based, viscosupplements covering the revenue growth of each sub-segment from 2016 to 2030.
During the first wave of the COVID-19 pandemic, numerous countries in the region stopped all nonemergency surgical procedures to free up resources, including healthcare professionals, to care for patients suffering from coronavirus infection; this impeded market growth in 2020.
However, the resumption of surgeries in the region will help revive the demand for surgery products in the coming years. Growing geriatric population, which is more prone to ailments, and rising awareness among individuals about treatment options are the key factors driving market growth.
Furthermore, high disposable income, owing to presence of developed economies, and well-established healthcare infrastructure & availability of skilled professionals are some of the factors contributing to market growth. Companies such as Smith & Nephew, VSY Biotechnology GmbH, and Aptissen S.A are increasingly focusing on expanding their businesses in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe orthopedic regenerative surgical products market , including forecasts for subscribers. This continent databook contains high-level insights into Europe orthopedic regenerative surgical products market from 2016 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account